ANAB
AnaptysBio, Inc.
NASDAQ · USHealthcareBiotechnology
$50.29-13.29%
Price as of Jul 20, 2026
ANAB valuation
AnaptysBio, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 15.11x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 114.81x
- Price / sales
- 6.30x
- Price / cash flow
- 326.82x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 6.26x
- EV / EBITDA
- 24.87x
- EV / EBIT
- 35.65x
- Market cap
- $1.5B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.